Kurs
-2,88%
Kurs
-2,88%
Kalender
Tid* | ||
2025-02-12 | 09:00 | Bokslutskommuniké 2024 |
2024-11-13 | - | Extra Bolagsstämma 2024 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-07-01 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2024-06-28 | - | Årsstämma |
2024-06-14 | - | Bokslutskommuniké 2023 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-06-12 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2023-06-09 | - | Årsstämma |
2023-04-28 | - | Bokslutskommuniké 2022 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2022-06-09 | - | Årsstämma |
2022-04-29 | - | Bokslutskommuniké 2021 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2021-06-09 | - | Årsstämma |
2021-04-30 | - | Bokslutskommuniké 2020 |
2020-09-11 | - | Extra Bolagsstämma 2020 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-06-11 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2020-06-10 | - | Årsstämma |
2020-04-15 | - | Bokslutskommuniké 2019 |
2019-08-28 | - | Kvartalsrapport 2019-Q2 |
2019-06-06 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2019-06-05 | - | Årsstämma |
2019-04-24 | - | Bokslutskommuniké 2018 |
2019-01-07 | - | Extra Bolagsstämma 2019 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-05-30 | - | Årsstämma |
2018-02-21 | - | Bokslutskommuniké 2017 |
2017-08-16 | - | Kvartalsrapport 2017-Q2 |
2017-06-08 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2017-06-07 | - | Årsstämma |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-11-18 | - | X-dag bonusutdelning ABTEC 1 |
2016-11-17 | - | Extra Bolagsstämma 2016 |
2016-11-17 | - | 15-10 2016-Q3 |
2016-08-17 | - | Kvartalsrapport 2016-Q2 |
2016-06-09 | - | X-dag ordinarie utdelning ABTEC 1.50 NOK |
2016-06-08 | - | Årsstämma |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-11-18 | - | Kvartalsrapport 2015-Q3 |
2015-08-19 | - | Kvartalsrapport 2015-Q2 |
2015-06-04 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2015-06-03 | - | Årsstämma |
2015-05-13 | - | Kvartalsrapport 2015-Q1 |
2015-02-11 | - | Bokslutskommuniké 2014 |
2014-11-26 | - | Kvartalsrapport 2014-Q3 |
2014-08-20 | - | Kvartalsrapport 2014-Q2 |
2014-06-11 | - | Årsstämma |
2014-05-21 | - | Kvartalsrapport 2014-Q1 |
2014-02-12 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-21 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | Kapitalmarknadsdag 2013 |
2013-06-12 | - | X-dag ordinarie utdelning |
2013-06-11 | - | Årsstämma |
2013-05-22 | - | Kvartalsrapport 2013-Q1 |
2013-02-13 | - | Bokslutskommuniké 2012 |
2012-11-27 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-17 | - | Bokslutskommuniké 2011 |
2011-11-30 | - | Kvartalsrapport 2011-Q3 |
2011-08-29 | - | Kvartalsrapport 2011-Q2 |
2011-06-17 | - | X-dag ordinarie utdelning |
2011-06-16 | - | Årsstämma |
2011-05-30 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Bioteknik |
2019-09-02 08:00:14
Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT" or the "Company") published on 28 August 2019 regarding exercise of warrants by certain primary insiders. As set out in that primary insider notice, Chairman of the Board Edvard Cock (through Blixen Invest AS) exercised 500,000 warrants and Board member Roger Hofseth (through Finnvik Eiendom AS) exercised 1,500,000 warrants. Upon such exercise and following expiry of the exercise period for the warrants, both Blixen Invest AS and Finnvik Eiendom AS surpassed thresholds for mandatory notification of ownership: * Blixen Invest AS will receive 500,000 new shares in the Company following exercise of warrants. Prior to such exercise, Blixen Invest AS hold 500,000 shares and votes in the Company, corresponding to 4.25% of the shares and votes outstanding in the Company as of today. Following such exercise, Blixen Invest AS will hold 1,000,000 shares and votes in the Company corresponding to 6.5% of the total outstanding shares and votes in the Company (calculated after issuance of the new shares after exercise of warrants). * Finnvik Eiendom AS will receive 1,500,000 new shares in the Company following exercise of warrants. Prior to such exercise, Finnvik Eiendom AS hold 2,187,000 shares and votes in the Company, corresponding to 18.79% of the shares and votes outstanding in the Company as of today. Following such exercise, Finnvik Eiendom AS will hold 3,687,000 shares and votes in the Company corresponding to 23.99% of the total outstanding shares and votes in the Company (calculated after issuance of the new shares after exercise of warrants). This information is subject to the disclosure requirements pursuant to sections 4-3 and 5-12 of the Norwegian Securities Trading Act.